Adaptive Biotechnologies President and COO Julie Rubinstein sold 57,180 shares of ADPT stock. The transaction amounted to approximately $826,251.
Adaptive Biotechnologies President Sells $826K in Company Stock
ADPTInsider SellingBiotechnologyExecutive Transactions



